Raised ICP Management — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Administer bolus hyperosmolar therapy with mannitol or hypertonic saline
The correct answer is C. Sustained ICP of 28 mmHg despite physiological optimisation and effective CSF drainage requires escalation, and intermittent bolus hyperosmolar therapy is the appropriate next lower-risk intervention. Mannitol increases plasma osmolality and produces an osmotic gradient drawing water from brain parenchyma; hypertonic saline has a similar osmotic effect while tending to support intravascular volume and arterial pressure. Agent selection depends on sodium, osmolality, renal function and haemodynamics. Decompressive craniectomy and barbiturate coma carry substantial morbidity and are reserved for intracranial hypertension refractory to lower-tier treatment. Cooling to 33°C is not routine ICP therapy and risks coagulopathy, infection and arrhythmia. A BIS target below 20 is not a validated ICP-management endpoint and may cause unnecessary cardiovascular depression.
Reference: Royal College of Anaesthetists, Raising the Standards: RCoA quality improvement compendium, Neuroanaesthesia section 12.5, Management of raised intracranial pressure in severe traumatic brain injury, 2020. https://rcoa.ac.uk/media/15651